For professionals in the chemical and pharmaceutical industries, a deep understanding of the chemical profile of active pharmaceutical ingredients (APIs) like Tylvalosin Tartrate is essential. This macrolide antibiotic, widely used in veterinary medicine, possesses specific chemical properties that dictate its formulation and efficacy.

Tylvalosin Tartrate is a semi-synthetic derivative of tylosin, belonging to the 16-membered macrolide class. Its molecular formula is C57H93NO25, and it is typically supplied as a white crystalline powder. As a tartrate salt, it offers improved solubility and stability, making it amenable for various pharmaceutical preparations, including water-soluble powders and feed premixes. The CAS number for Tylvalosin Tartrate is 63428-13-7, a critical identifier for procurement and regulatory purposes.

The chemical structure of Tylvalosin Tartrate contributes to its mechanism of action: inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit. This targeted action is crucial for its effectiveness against a range of veterinary pathogens. As a pharmaceutical intermediate, its purity and consistent chemical composition are paramount. Manufacturers adhere to strict synthesis and purification processes to ensure these requirements are met.

When sourcing Tylvalosin Tartrate, buyers should look for suppliers who can provide detailed chemical specifications, including purity levels, residual solvents, and heavy metal content. Information regarding its stability under various storage conditions is also important for formulators. A reliable manufacturer, such as those with GMP certifications, will ensure that each batch of Tylvalosin Tartrate consistently meets these chemical profiles.

The market for veterinary APIs like Tylvalosin Tartrate is driven by demand for effective animal health solutions. Procuring this chemical raw material from established manufacturers and suppliers, particularly those with significant production capacity and a strong track record in the industry, guarantees access to a high-quality product. This is vital for companies involved in developing and manufacturing veterinary pharmaceuticals for swine and poultry health.